Oxurion NV: Oxurion Announces Results of the Extraordinary and Annual Shareholders' Meetings of 3 May 2022 and Invitation to the Extraordinary Shareholders' Meeting of 24 May 2022
Leuven, Belgium, Boston, MA, US - May 6, 2022 - 07.00 PM CET - Oxurion NV(Euronext Brussels: OXUR) (the "Company" or "Oxurion"), a biopharmaceutical company developing next generation